about
Antibiotics for persistent cough or wheeze following acute bronchiolitis in childrenRespiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and AdolescentsMobile phones support adherence and retention of indigenous participants in a randomised controlled trial: strategies and lessons learnt.Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasisRandomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocolA single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial.Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.Age-specific cluster of cases of serotype 1 Streptococcus pneumoniae carriage in remote indigenous communities in Australia.Feasibility of a Peer-Led Asthma and Smoking Prevention Project in Australian Schools with High Indigenous Youth.Retrospective review of 200 children hospitalised with acute asthma. Identification of intervention points: a single centre study.Culture-specific programs for children and adults from minority groups who have asthma.Antibiotics for persistent cough or wheeze following acute bronchiolitis in children.Risk factors for adverse outcomes of Indigenous infants hospitalized with bronchiolitis.Can mobile phone multimedia messages and text messages improve clinic attendance for Aboriginal children with chronic otitis media? A randomised controlled trial.Accuracy of cough reporting by carers of Indigenous children.Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections.Defining lower airway bacterial infection in children with chronic endobronchial disorders.Further clinical trials on macrolides for bronchiolitis in infants are unnecessary.'Good enough' is 'not enough' when managing indigenous adults with bronchiectasis in Australia and New Zealand.Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine.Clinical course of chronic suppurative lung disease and bronchiectasis in Alaska Native childrenEpidemiology of ocular trauma in the Indigenous versus non-Indigenous population in the Top EndHOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trialA decade on: Follow-up findings of indigenous children with bronchiectasisPerspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis-Can It Improve Clinical Care?
P50
Q24202367-AD4A8600-098E-4D62-ACE5-7AD3A091DD81Q30210217-C5B32B20-17AA-4922-8D98-C469B69152CEQ30223383-3BC7028B-F969-40D2-9142-8087EBFA390DQ30235406-821F1555-E3FB-45C6-8684-C546093FD75AQ33794413-4C31CC0E-60EB-4CFE-BAA0-3417988A4F58Q34935189-3F0C43FD-7BA7-4CBB-9734-00876DA9380BQ34980321-13CBFE34-E83D-4569-BBD3-1DB94EE523F5Q35004975-277AA367-0DE1-4B06-A394-87DA9A3DA565Q35506907-C85E1E98-AD59-4404-B189-9A889B4AA3E1Q37353506-C3DCD072-7824-4C08-B9BA-1C60687CF24DQ37675361-E0BC88D7-89ED-4B66-9696-480C0D8C2A18Q38174181-A4BD0074-2DD2-4A44-A9DD-F8E9F859E58EQ38614681-B43F112B-562B-4B7A-BC03-81A776C02FC2Q38614685-AAE697ED-439A-4513-9210-C08E7DA8CEA9Q38942122-FFBAA3B7-86EB-40DF-81F5-1070D6EA6E72Q39235328-D894257B-FF08-4981-B562-2DEE2B275DD2Q40094339-870DDB4A-A095-486A-AD62-4C953504CF6DQ40382092-56AFA67A-B882-4125-812E-B4617F3D3314Q47562273-FB4F29EE-A91B-4DFF-892B-D2A90BA6CD17Q50972557-9CF62145-B5B1-4B05-BECC-D1427A049EB9Q52658792-18DC861F-0E85-4A86-BC2D-EAEC3871D43DQ54266987-F7077193-2761-448D-BB33-7AD8544F29D7Q57459703-A149A6B5-A067-4AAC-91C8-0A45670930C2Q58605361-E6E1DA3F-B63B-472F-A7D4-7E55BBDB5F13Q64092119-68478E7C-9812-4609-A651-9C137347AE46Q89874758-44D9BD7A-A8D2-4C00-ACD3-2CC5BEDE9DA2Q91319141-53E7B75F-4729-4FE5-9D2F-AE6F4580488E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
G McCallum
@en
G McCallum
@nl
type
label
G McCallum
@en
G McCallum
@nl
prefLabel
G McCallum
@en
G McCallum
@nl
P31
P496
0000-0002-0210-1468